NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Thursday reported a loss of $22.4 million in its first quarter.
The Newton, Massachusetts-based company said it had a loss of $1.24 per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.45 per share.
The pharmaceutical company posted revenue of $35.1 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $33.9 million.
Karyopharm Therapeutics expects full-year revenue in the range of $130 million to $150 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
